SHADAN MARTHA 4

What Happened

• Martha Shadan, a director of Lemaitre Vascular, was credited with dividend-equivalent rights that converted into a total of 3.445 shares (derivative awards) on March 26, 2026. Each item was recorded at $0.00 per share, so no cash changed hands. These are dividend-equivalent units tied to previously granted restricted stock units (RSUs) and performance share units (PSUs).

Key Details

• Transaction date: 2026-03-26; Form 4 filed 2026-03-30 (appears to be filed within the standard two-business-day window).
• Items credited (all derivative, acquired at $0.00):
  • 0.394 shares (dividend equivalent on RSU grant 12/8/2023)
  • 0.472 shares (dividend equivalent on PSU grant 12/8/2023)
  • 0.643 shares (dividend equivalent on RSU grant 12/6/2024)
  • 0.728 shares (dividend equivalent on PSU grant 12/6/2024)
  • 1.208 shares (dividend equivalent on RSU grant 12/10/2025)
• Total credited: 3.445 shares; reported value = $0.00 (these are not open-market purchases).
• Shares owned after the transaction: not reported in the provided data.
• Footnotes: each credited amount represents a dividend-equivalent right that accrues and vests proportionately with the underlying RSU or PSU and is the economic equivalent of one share.

Context

• These entries are derivative awards (dividend equivalents) that reflect payouts tied to existing equity awards; they do not represent a cash purchase or sale in the open market. Such accruals are routine and generally less indicative of a director’s near-term market sentiment than outright purchases or sales.